Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-05-14 @ 7:29 PM
Study NCT ID:
NCT04400994
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-08
First Post:
2020-04-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
Sponsor:
The University of Hong Kong
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UW19-671
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None